Skip to content
← Back to this collection

PUBLICATIONS · 10192340

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Int J Radiat Oncol Biol Phys
Publication date
1999 Mar 15
First author
Mandell LR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):947-9. doi: 10.1016/s0360-3016(98)00503-3.
    note
    Source null
    related pmid
    10192338
    relationship
    Comment in

Authors and identifiers

  1. name
    Mandell LR
    type
    Author
  2. name
    Kadota R
    type
    Author
  3. name
    Freeman C
    type
    Author
  4. name
    Douglass EC
    type
    Author
  5. name
    Fontanesi J
    type
    Author
  6. name
    Cohen ME
    type
    Author
  7. name
    Kovnar E
    type
    Author
  8. name
    Burger P
    type
    Author
  9. name
    Sanford RA
    type
    Author
  10. name
    Kepner J
    type
    Author
  11. name
    Friedman H
    type
    Author
  12. name
    Kun LE
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mandell LR
    type
    Author
  2. name
    Kadota R
    type
    Author
  3. name
    Freeman C
    type
    Author
  4. name
    Douglass EC
    type
    Author
  5. name
    Fontanesi J
    type
    Author
  6. name
    Cohen ME
    type
    Author
  7. name
    Kovnar E
    type
    Author
  8. name
    Burger P
    type
    Author
  9. name
    Sanford RA
    type
    Author
  10. name
    Kepner J
    type
    Author
  11. name
    Friedman H
    type
    Author
  12. name
    Kun LE
    type
    Author
bibliography ids
  1. nci-bib-63a4fe94dc4f3da19726faa2
book metadata
content sha256
b44911d028ef4b8f251508949f67f8adc9c1c43fc2707e54db55e4746f433b62
document type
citation
dois
  1. 10.1016/s0360-3016(98)00501-x
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:10192340
immutable id
pubmed:10192340@b44911d028ef4b8f251508949f67f8adc9c1c43fc2707e54db55e4746f433b62
journal
abbreviation
Int J Radiat Oncol Biol Phys
issn electronic
Source null
issn print
0360-3016
issue
5
name
International journal of radiation oncology, biology, physics
nlm unique id
7603616
pages
959-64
volume
43
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):947-9. doi: 10.1016/s0360-3016(98)00503-3.
    note
    Source null
    related pmid
    10192338
    relationship
    Comment in
outcomes validated
false
pmid
10192340
provenance
batch id
322200bb755447812cbb
provider
NCBI PubMed ESummary
record sha256
486ba6118709507b1e16cf39cc169eb81767bbbfe819933c3c3391fdee15190d
response sha256
943a99f9971dfe66ed403e5c181642ea57c7276fe995e9a6a8c892602df084fa
retrieved at
2026-09-09T23:45:33.802271+00:00
publication date
display
1999 Mar 15
precision
day
year
1999
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/10192340/
title
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.

Preserved source evidence · Not medical advice